AstraZeneca Group plc Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (42)

Latest Posts

About This Stock More About This Stock
Cempra Plunges To 52-Week Low, Shire Drug Label Expanded
Article By: Arpita Dutt
Friday, December 30, 2016 10:33 AM EST
It was a relatively slow week for pharma stocks though a couple of companies suffered regulatory setbacks with the FDA issuing complete response letters (CRLs) for their regulatory applications.
In this article: AMPH, AZN, BMY, CEMP, MRK, MYL, SHPG
Read
Week In Review: JHL Biotech Signs $257 Million Biosimilar Deal With Sanofi
Article By: ChinaBio® Today
Saturday, December 10, 2016 12:44 PM EST
JHL Biotech, a Taiwan-China biologics company, signed a $257 million partnership agreement that gives Sanofi rights to market a JHL clinical-stage rituximab biosimilar, initially for China.
In this article: AZN, NVS, SNY, CGIX, BGNE
Read
E Better Than The Maestro
Article By: Vivian Lewis
Monday, November 28, 2016 11:53 PM EST
I hope my screed last week about frothy dry bulk carrier stocks persuaded you not to get into that thicket—or to sell out if you had been lured in. The group, led by Dryships, which we sold ages ago, duly crashed.
In this article: AGN, AZN, BCS, BHP, BP, CPA, CRH, CX, FCX, GSK, MINT, RBS, SLB, SAN, VALE, FCO, DGRLY, GTOMY, LMDCF, MXCHF, NPSNY, TCTZF, TESO, DRYS, INFY, TEVA, CUBA, GLD, MNILY, FBASF, VRGDF
Read
Lilly Alzheimer's Drug Fails, J&J In Acquisition Talks With ALIOF
Article By: Arpita Dutt
Monday, November 28, 2016 11:59 AM EST
Does Johnson & Johnson’s interest in acquiring Actelion imply the beginning of increased merger and acquisition (M&A) activity in the pharma and biotech sector?
In this article: AGN, AZN, BMY, JNJ, LLY, MRK, ALIOF
Read
Everything Is Soaring As Trump Makes Buying Stuff Great Again
Article By: Tyler Durden
Thursday, November 10, 2016 7:06 AM EST
The global repricing of inflation expectations continues at a feverish pace in the aftermath of the Trump victory, leading to another surge in US equity futures, up 15 points or 0.7% to 2175, with Asian and European stock market all jumping.
In this article: AZN, BX, GS, VIV, SPY, DAX
Read

PARTNER HEADLINES

Latest Tweets for $AZN

No tweets yet!